Ionis med added to Aetna precertification list
Ionis Pharmaceuticals Inc IONS shares were trading up 6.61 percent Tuesday on news that Aetna Inc AET added Spinraza — a drug developed by Ionis and licensed by Biogen Inc BIIB — to its precertification list.
However, an Aetna representative told Benzinga the “appearance on this list does not indicate one way or the other what the clinical policy will be.”
“As with all new FDA-approved products, we will conduct a full clinical review of Spinraza (nusinersen) to determine our clinical coverage policy,” the spokesperson said. “We have not yet completed this review.”